Complement component C3–The “Swiss Army Knife” of innate immunity and host defense

D Ricklin, ES Reis, DC Mastellos, P Gros… - Immunological …, 2016 - Wiley Online Library
As a preformed defense system, complement faces a delicate challenge in providing an
immediate, forceful response to pathogens even at first encounter, while sparing host cells in …

Compstatins: the dawn of clinical C3-targeted complement inhibition

C Lamers, DC Mastellos, D Ricklin… - Trends in pharmacological …, 2022 - cell.com
Despite the growing recognition of the complement system as a major contributor to a variety
of clinical conditions, the therapeutic arsenal has remained scarce. The introduction of an …

A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways

K Ritis, M Doumas, D Mastellos, A Micheli… - The Journal of …, 2006 - journals.aai.org
Neutrophils and complement are key sentinels of innate immunity and mediators of acute
inflammation. Recent studies have suggested that inflammatory processes modulate …

Advances in protein structure prediction and de novo protein design: A review

CA Floudas, HK Fung, SR McAllister… - Chemical Engineering …, 2006 - Elsevier
This review provides an exposition to the important problems of (i) structure prediction in
protein folding and (ii) de novo protein design. The recent advances in protein folding are …

[HTML][HTML] Complement component C3: a structural perspective and potential therapeutic implications

BV Geisbrecht, JD Lambris, P Gros - Seminars in immunology, 2022 - Elsevier
As the most abundant component of the complement system, C3 and its proteolytic
derivatives serve essential roles in the function of all three complement pathways. Central to …

Complement‐targeted therapeutics: an emerging field enabled by academic drug discovery

C Lamers, D Ricklin, JD Lambris - American Journal of …, 2023 - Wiley Online Library
Within a short few years, the number of complement inhibitors that are either approved for
therapeutic application or evaluated in late‐stage clinical trials has expanded remarkably …

Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis

HF Langer, KJ Chung, VV Orlova… - Blood, The Journal …, 2010 - ashpublications.org
Beyond its role in immunity, complement mediates a wide range of functions in the context of
morphogenetic or tissue remodeling processes. Angiogenesis is crucial during tissue …

Insight into mode-of-action and structural determinants of the compstatin family of clinical complement inhibitors

C Lamers, X Xue, M Smieško, H van Son… - Nature …, 2022 - nature.com
With the addition of the compstatin-based complement C3 inhibitor pegcetacoplan, another
class of complement targeted therapeutics have recently been approved. Moreover …

Compstatin: a complement inhibitor on its way to clinical application

D Ricklin, JD Lambris - Current Topics in Complement II, 2008 - Springer
Therapeutic modulation of the human complement system is considered a promising
approach for treating a number of pathological conditions. Owing to its central position in the …

[HTML][HTML] New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties

H Qu, D Ricklin, H Bai, H Chen, ES Reis… - Immunobiology, 2013 - Elsevier
Therapeutic modulation of the complement system has become increasingly important in
line with the growing recognition of the role of complement in numerous diseases …